Home|DSIJArticleDetail

Low PE stock under Rs 30 hits 5 per cent upper circuit as the company reports a 400 per cent jump in operating profit!
Low PE stock under Rs 30 hits 5 per cent upper circuit as the company reports a 400 per cent jump in operating profit!

Low PE stock under Rs 30 hits 5 per cent upper circuit as the company reports a 400 per cent jump in operating profit!

The stock is up by 15 per cent in 15 days and over 50 per cent in just 1 year.

Kiran Shroff Article rating: 4.4

The company has a market cap of Rs 25.66 crore. The shares of the company have a PE of 7.76x whereas the industry PE is 32.10x.

Multibagger stock below Rs 30: Keep an eye on this stock, which was locked in the upper circuit on January 30
Multibagger stock below Rs 30: Keep an eye on this stock, which was locked in the upper circuit on January 30

Multibagger stock below Rs 30: Keep an eye on this stock, which was locked in the upper circuit on January 30

The stock gave multibagger returns of 132.91 per cent in just 1 month whereas BSE small-cap index was down by 5.39 per cent.

Kiran Shroff Article rating: 4.1

The stock gave multibagger returns of 132.91 per cent in just 1 month whereas BSE small-cap index was down by 5.39 per cent.

This company delivered a 1,500 per cent dividend on its per share face value
This company delivered a 1,500 per cent dividend on its per share face value

This company delivered a 1,500 per cent dividend on its per share face value

The company’s board of directors has recommended a final dividend of Rs 144 per share of Rs 10 each. The company has already paid two interim dividends of Rs 3 each per share. The total dividend for the year, works out to Rs 150 per share of Rs 10 each.

Mandar Wagh Article rating: 5.0

The company’s board of directors has recommended a final dividend of Rs 144 per share of Rs 10 each. The company has already paid two interim dividends of Rs 3 each per share. The total dividend for the year, works out to Rs 150 per share of Rs 10 each.    

DSIJ MINDSHARE

Mkt Commentary2-May, 2024

Multibaggers2-May, 2024

Multibaggers2-May, 2024

Penny Stocks2-May, 2024

Penny Stocks2-May, 2024

Knowledge

Technical1-May, 2024

General26-Apr, 2024

Fundamental21-Apr, 2024

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

SEBI Registered Research Analyst Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INH000006396
Validity: Oct 05, 2018 - Perpetual

View Registration Certificate

SEBI Registered Investment Adviser Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INA000001142
Validity: Aug 19, 2019 - Perpetual

View Registration Certificate

Registered Address:
419-A, 4th floor, Arun Chambers,
Tardeo, Next to AC Market, Mumbai - 400 034.
Tel: +91 022-43476012/13/14/15 | Email: service@dsij.in
CIN No.: U22120MH2003PTC139276
GST No.: 27AACCR4303G1ZP
BASL Membership ID: 1346

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR

Disclaimer: "Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors"

Investment in securities market is subject to market risks. Read all the related documents carefully before investing.

Any act of copying, reproducing, or distributing the content whether wholly or in part, for any purpose without the permission of DSIJ is strictly prohibited and shall be deemed to be copyright infringement.

Disclosures | Terms & Condition | Privacy Statement | WhiteList